BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chopra T, Kandukurti K, Shah S, Ahmed R, Panesar M. Understanding nephrogenic systemic fibrosis. Int J Nephrol. 2012;2012:912189. [PMID: 23193473 DOI: 10.1155/2012/912189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Dohan A, Eveno C, Oprea R, Pautrat K, Placé V, Pocard M, Hoeffel C, Boudiaf M, Soyer P. Diffusion-weighted MR imaging for the diagnosis of abscess complicating fistula-in-ano: preliminary experience.Eur Radiol. 2014;24:2906-2915. [PMID: 25038854 DOI: 10.1007/s00330-014-3302-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
2 Zhang R, Rose WN. Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis. Case Rep Dermatol Med. 2017;2017:3240287. [PMID: 28695022 DOI: 10.1155/2017/3240287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Clin Rev Allergy Immunol 2017;53:306-36. [PMID: 28712039 DOI: 10.1007/s12016-017-8625-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 36] [Article Influence: 21.0] [Reference Citation Analysis]
4 Chen C, Wu CQ, Chen TW, Tang MY, Zhang XM. Molecular Imaging with MRI: Potential Application in Pancreatic Cancer. Biomed Res Int 2015;2015:624074. [PMID: 26579537 DOI: 10.1155/2015/624074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Schmidli J, Widmer MK, Basile C, de Donato G, Gallieni M, Gibbons CP, Haage P, Hamilton G, Hedin U, Kamper L, Lazarides MK, Lindsey B, Mestres G, Pegoraro M, Roy J, Setacci C, Shemesh D, Tordoir JH, van Loon M, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Kakkos S, Koncar I, Lindholt J, Naylor R, Vega de Ceniga M, Vermassen F, Verzini F, Esvs Guidelines Reviewers, Mohaupt M, Ricco J, Roca-tey R. Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). European Journal of Vascular and Endovascular Surgery 2018;55:757-818. [DOI: 10.1016/j.ejvs.2018.02.001] [Cited by in Crossref: 225] [Cited by in F6Publishing: 133] [Article Influence: 75.0] [Reference Citation Analysis]
6 Dai Y, Wu C, Wang S, Li Q, Zhang M, Li J, Xu K. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent. Nanomedicine 2018;14:547-55. [PMID: 29253637 DOI: 10.1016/j.nano.2017.12.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
7 Caschera L, Lazzara A, Piergallini L, Ricci D, Tuscano B, Vanzulli A. Contrast agents in diagnostic imaging: Present and future. Pharmacol Res 2016;110:65-75. [PMID: 27168225 DOI: 10.1016/j.phrs.2016.04.023] [Cited by in Crossref: 49] [Cited by in F6Publishing: 25] [Article Influence: 9.8] [Reference Citation Analysis]
8 Leow KS, Wu YW, Tan CH. Renal-related adverse effects of intravenous contrast media in computed tomography. Singapore Med J 2015;56:186-93. [PMID: 25917468 DOI: 10.11622/smedj.2015057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
9 Carrasco Muñoz S, Calles Blanco C, Marcin J, Fernández Álvarez C, Lafuente Martínez J. Contrastes basados en gadolinio utilizados en resonancia magnética. Radiología 2014;56:21-8. [DOI: 10.1016/j.rx.2014.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
10 Ploussi AG, Gazouli M, Stathis G, Kelekis NL, Efstathopoulos EP. Iron Oxide Nanoparticles as Contrast Agents in Molecular Magnetic Resonance Imaging: Do They Open New Perspectives in Cardiovascular Imaging? Cardiology in Review 2015;23:229-35. [DOI: 10.1097/crd.0000000000000055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H. Current status of nephrogenic systemic fibrosis. Clin Radiol. 2014;69:661-668. [PMID: 24582176 DOI: 10.1016/j.crad.2014.01.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 48] [Article Influence: 11.1] [Reference Citation Analysis]
12 Chen R, Ling D, Zhao L, Wang S, Liu Y, Bai R, Baik S, Zhao Y, Chen C, Hyeon T. Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents. ACS Nano 2015;9:12425-35. [PMID: 26567968 DOI: 10.1021/acsnano.5b05783] [Cited by in Crossref: 99] [Cited by in F6Publishing: 84] [Article Influence: 16.5] [Reference Citation Analysis]
13 Alford A, Rich M, Kozlovskaya V, Chen J, Sherwood J, Bolding M, Warram J, Bao Y, Kharlampieva E. Ultrasound‐Triggered Delivery of Anticancer Therapeutics from MRI‐Visible Multilayer Microcapsules. Adv Therap 2018;1:1800051. [DOI: 10.1002/adtp.201800051] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
14 Bhargava V, Singh K, Meena P, Sanyal R. Nephrogenic systemic fibrosis: A frivolous entity. World J Nephrol 2021;10:29-36. [PMID: 34136369 DOI: 10.5527/wjn.v10.i3.29] [Reference Citation Analysis]
15 Dewan A, Zwerner J, Abraham JL, Boyd A, Zic J. Chronic, dusky, indurated plaques on the legs of a 31-year-old woman. Clin Exp Dermatol 2016;41:328-30. [DOI: 10.1111/ced.12761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]